| A review of rare disease policies and orphan drug reimbursement systems in 12 Eurasian countries M Czech, A Baran-Kooiker, K Atikeler, M Demirtshyan, K Gaitova, ... Frontiers in public health 7, 416, 2020 | 99 | 2020 |
| Türkiye özel ve kamu sağlik sigortaciliği prim/hasarsağlik harcamasi değerlendirmesi G Koçkaya, K Atikeler, F Yenilmez Sosyal Güvence, 82-101, 2016 | 21 | 2016 |
| Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries EK Atikeler, G Özçelikay SpringerPlus 5, 1-8, 2016 | 15 | 2016 |
| Access to medicines in Turkey: Evaluation of the process of medicines brought from abroad EK Atikeler, HGMB Leufkens, W Goettsch International Journal of Technology Assessment in Health Care 36 (6), 585-591, 2020 | 8 | 2020 |
| Cost effectiveness and economic value of obesity surgery for Turkey (CEVOS-T) G Koçkaya, FB Yenilmez, G Ergin, K Atikeler, M Tatar Obesity Medicine 1, 33-37, 2016 | 8 | 2016 |
| Operational cost of obesity surgery in Turkey G Koçkaya, FB Yenilmez, G Ergin, K Atikeler, M Tatar, MM Özmen, ... Eur J Endosc Laparosc Surg 1 (2), 78-83, 2014 | 6 | 2014 |
| Applicability of the EVIDEM multi-criteria decision analysis framework for orphan drugs Ñ results from a study in 7 Eurasian countries A Baran-Kooiker, K Atikeler, K Gaitova, M Holownia-Voloskova, ... Acta Poloniae Pharmaceutica 76 (3), 2019 | 5 | 2019 |
| Health technology assessment in Türkiye: current status and perspectives on future implementation EK Atikeler, AN Fasseeh, AK Mantel-Teeuwisse, Z Çalışkan, ZG Öner, ... Health Policy and Technology 12 (1), 100701, 2023 | 4 | 2023 |
| Cost Evaluation of Inhaler Therapies Used in Respiratory Diseases: 1998--2015 Period in Turkey B Bayar, NU Kutkan, EŞ Yılmaz, Ç Tolun, E Doğan, EK Atikeler, EH Vural, ... Value in health regional issues 13, 31-38, 2017 | 4 | 2017 |
| What is The Level of Transparency in Health Technology Assessment Process in Hungary, Romania and Turkey? M Subtirelu, OC Mic, D Daneasa, M Csanadi, K Atikeler, E Dogan, ... Value in Health 19 (7), A634-A635, 2016 | 3 | 2016 |
| Comparison of pharmaceutical pricing and reimbursement systems in turkey and certain other EU countries K Atikeler, G Ozcelikay Value in Health 18 (7), A572, 2015 | 3 | 2015 |
| PP138 current status of healthcare decision making and future perspective of the health technology assessment implementation roadmap in Turkey EK Atikeler, AN Fasseeh, B Leufkens, W Goettsch International Journal of Technology Assessment in Health Care 36 (S1), 16-17, 2020 | 2 | 2020 |
| Comparison of The Reimbursement Decisions of Pharmaceuticals In Hungary, Romania And Turkey K Atikeler, M Csanadi, M Subtirelu, A Baran, D Daneasa, AL Preda, ... Value in Health 20 (9), A695, 2017 | 2 | 2017 |
| PND17 Comparing Cost of Therapeutic Plasma Exchange and Intravenous Immunoglobulin Infusion in Treating Guillain-BarrÉ Syndrome K Atikeler, E Tuna, G Kockaya Value in Health 15 (7), A548, 2012 | 2 | 2012 |
| Value of Life And Cost of Pre-Mature Deaths With The Perspective Of Productivity As Net Tax Revenue: A Comparison In Usa, Canada, Japan and Australia FB Yenilmez, E Tuna, K Atikeler, G Kockaya, M Tatar Value in Health 17 (7), A423, 2014 | 1 | 2014 |
| Availability of risk sharing agreements in the Turkish pharmaceutical sector E Tuna, M Tatar, G Ergin, A Senturk, K Atikeler Value in Health 17 (7), A415, 2014 | 1 | 2014 |
| Classification of Drugs Bringing from Abroad in Turkey According to Their Atc Codes E Tuna, K Atikeler, Z Calýskan Value in Health 17 (7), A788, 2014 | 1 | 2014 |
| Comparison Retail Prices of Drug Prices Between Turkey and European Countries G Kockaya, K Atikeler, A Esen, E Tuna Value in Health 16 (7), A457, 2013 | 1 | 2013 |
| Cost of Obesity and Economic Value of Obesity Surgery for Turkey (CEVOS-T) G Kockaya, M Tatar, G Ergin, K Atikeler Value in Health 16 (7), A381, 2013 | 1 | 2013 |
| Operational Cost of Obesity Surgery for Turkey G Kockaya, G Ergin, K Atikeler, M Tatar, M Ozmen, M Gorgun, H Coskun SPRINGER, 2013 | 1 | 2013 |
